Cipher Pharmaceuticals Stock Buy Hold or Sell Recommendation
| CPH Stock | CAD 11.35 0.33 2.83% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Cipher Pharmaceuticals is 'Sell'. The recommendation algorithm takes into account all of Cipher Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Cipher Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Cipher and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Cipher Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Cipher |
Execute Cipher Pharmaceuticals Buy or Sell Advice
The Cipher recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cipher Pharmaceuticals. Macroaxis does not own or have any residual interests in Cipher Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cipher Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Cipher Pharmaceuticals Trading Alerts and Improvement Suggestions
| Cipher Pharmaceuticals generated a negative expected return over the last 90 days | |
| Cipher Pharmaceuticals is unlikely to experience financial distress in the next 2 years | |
| The company has C$353,000 in debt which may indicate that it relies heavily on debt financing | |
| About 42.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Cipher Pharmaceuticals Inc. surges 13 individual investors who own 57 percent shares profited along with insiders - Simply Wall St |
Cipher Pharmaceuticals Returns Distribution Density
The distribution of Cipher Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Cipher Pharmaceuticals' future price movements. The chart of the probability distribution of Cipher Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Cipher Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cipher Pharmaceuticals returns is essential to provide solid investment advice for Cipher Pharmaceuticals.
| Mean Return | -0.44 | Value At Risk | -4.59 | Potential Upside | 2.99 | Standard Deviation | 2.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cipher Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cipher Pharmaceuticals Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 2.8M | 11.4M | 8.3M | 11.0M | 12.6M | 13.3M | |
| Free Cash Flow | 10.9M | 13.8M | 10.5M | 15.9M | 18.2M | 19.1M | |
| Depreciation | 1.2M | 701K | 989K | 1.2M | 1.4M | 1.4M | |
| Other Non Cash Items | 5.7M | 652K | (109K) | (788K) | (906.2K) | (860.9K) | |
| Capital Expenditures | 1.3M | 760K | 81K | 144K | 165.6K | 157.3K | |
| Net Income | 4.4M | 7.8M | 26.6M | 20.4M | 23.4M | 24.6M | |
| End Period Cash Flow | 9.1M | 20.5M | 28.8M | 39.8M | 45.8M | 48.1M | |
| Change To Inventory | 151K | (758K) | (502K) | (830K) | (747K) | (709.7K) | |
| Net Borrowings | (9.9M) | (7.9M) | (828K) | (58K) | (52.2K) | (49.6K) | |
| Change To Netincome | 4.1M | 4.2M | 677K | (14.0M) | (12.6M) | (12.0M) | |
| Investments | (760K) | 0.0 | (81K) | (144K) | (165.6K) | (173.9K) |
Cipher Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cipher Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cipher Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cipher stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.41 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | -0.12 |
Cipher Pharmaceuticals Volatility Alert
Cipher Pharmaceuticals exhibits very low volatility with skewness of 0.64 and kurtosis of 6.88. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cipher Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cipher Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cipher Pharmaceuticals Fundamentals Vs Peers
Comparing Cipher Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cipher Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Cipher Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cipher Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cipher Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cipher Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cipher Pharmaceuticals to competition |
| Fundamentals | Cipher Pharmaceuticals | Peer Average |
| Return On Equity | 0.18 | -0.31 |
| Return On Asset | 0.0506 | -0.14 |
| Profit Margin | 0.60 % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 343.74 M | 16.62 B |
| Shares Outstanding | 25.59 M | 571.82 M |
| Shares Owned By Insiders | 41.96 % | 10.09 % |
| Shares Owned By Institutions | 1.50 % | 39.21 % |
| Number Of Shares Shorted | 18.27 K | 4.71 M |
| Price To Earning | 21.55 X | 28.72 X |
| Price To Book | 2.09 X | 9.51 X |
| Price To Sales | 10.98 X | 11.42 X |
| Revenue | 21.16 M | 9.43 B |
| Gross Profit | 21.38 M | 27.38 B |
| EBITDA | 11.26 M | 3.9 B |
| Net Income | 20.38 M | 570.98 M |
| Cash And Equivalents | 9.25 M | 2.7 B |
| Cash Per Share | 0.34 X | 5.01 X |
| Total Debt | 353 K | 5.32 B |
| Debt To Equity | 62.30 % | 48.70 % |
| Current Ratio | 1.06 X | 2.16 X |
| Book Value Per Share | 3.86 X | 1.93 K |
| Cash Flow From Operations | 16 M | 971.22 M |
| Short Ratio | 0.45 X | 4.00 X |
| Earnings Per Share | 0.90 X | 3.12 X |
| Target Price | 16.7 | |
| Beta | 1.14 | -0.15 |
| Market Capitalization | 290.44 M | 19.03 B |
| Total Asset | 86.03 M | 29.47 B |
| Retained Earnings | 66.27 M | 9.33 B |
| Working Capital | 43.02 M | 1.48 B |
| Net Asset | 86.03 M |
Cipher Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cipher . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cipher Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Cipher Pharmaceuticals? Buying financial instruments such as Cipher Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cipher Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.